One ‐year clinical outcomes and multislice computed tomography angiographic results following implantation of the NeoVas bioresorbable sirolimus‐eluting scaffold in patients with single de novo coronary artery lesions

ConclusionsThis study demonstrated the safety and efficacy of the NeoVas scaffold for patients with single de novo coronary artery lesions at 1 year of follow‐up. Noninvasive MSCT data confirmed vessel patency and the maintenance of vessel dimensions following implantation of the NeoVas bioresorbable sirolimus‐eluting scaffold.

Source: Catheterization and Cardiovascular Interventions - February 2, 2018 Category: Cardiovascular & Thoracic Surgery Authors: Xiao ‐Zeng Wang, Yao‐Jun Zhang, Guo‐Sheng Fu, Quan‐Min Jing, Bo Xu, Ya‐Ling Han Tags: CORONARY ARTERY DISEASE Source Type: research